Some recent developments in the design of adaptive clinical trials
DOI:
https://doi.org/10.6092/issn.1973-2201/3653Abstract
For clinical trials that compare two or more competing treatments, the literature proposes several randomization rules that aim at favouring, at each stage of the trial, the treatment that appears to be best. In two papers the present authors have suggested criteria of optimal allocation that combine inferential precision and ethical gain by means of flexible weights, in order to achieve a good trade-off between efficiency and ethical concerns. The ensuing optimal allocation of the treatments can be targeted by a suitable response- adaptive randomization rule. The purpose of this paper is to illustrate and extend the results previously obtained by the authors to a wider range of statistical models for comparative trials. Methods for implementing these designs are given. Some numerical examples are included in order to enhance the applicability.References
A. BALDI ANTOGNINI, A. GIOVAGNOLI (2005), On the large sample optimality of sequential designs for comparing two or more treatments, “Sequential Analysis”, 24, pp. 205-217.
A. BALDI ANTOGNINI, A. GIOVAGNOLI (2010), Compound optimal allocation for individual and collective ethics in binary clinical trials, “Biometrika”, 97, pp. 935-946.
A. BALDI ANTOGNINI, M. ZAGORAIOU (2010), Covariate adjusted designs for combining efficiency, ethics and randomness in normal response trials, in A. GIOVAGNOLI, A.C. ATKINSON, B. TORSNEY (eds.) and C. MAY (co-ed.), mODa 9 - Advances in Model Oriented Design and Analysis, Springer-Verlag, Heidelberg.
A. BALDI ANTOGNINI, M. ZAGORAIOU (2011), The Covariate-adaptive biased coin design for balancing clinical trials in the presence of prognostic factors, “Biometrika”, 98, pp. 519-535.
S. C. CHOW, M. CHANG (2007), Adaptive Design Methods in Clinical Trials, Chapman and Hall/CRC.
FDA U.S DEPARTMENT OF HEALTH AND HUMAN SERVICES (2004), Challenge and Opportunity on the Critical Path to New Medicinal Products, available at: www.fda.gov/downloads/ScienceResearch/SpecialTopics/CriticalPathInitiative/CriticalPathOpportunitiesReports/ucm 113411.pdf
F. HU, L.X. ZHANG (2004), Asymptotic properties of doubly adaptive biased coin designs for multi treatment clinical trials, “The Annals of Statistics”, 32, pp. 268-301.
F. HU, L.X. ZHANG, X. HE (2009), Efficient randomized-adaptive designs, “The Annals of Statistics”, 37, pp. 2543-2560.
F. HU, W.F. ROSENBERGER (2006), The Theory of Response-Adaptive Randomization in Clinical Trials, Wiley & Sons, New York.
A. IVANOVA (2003), A play-the-winner type urn model with reduced variability, “Metrika”, 58, pp. 1-13.
L.J. WEI, S. DURHAM (1978), The randomized play-the-winner rule in medical trials, “Journal of the American Statistical Association”, 73, pp. 840-843.
M. ZELEN (1969), Play-the-winner rule and the controlled clinical trials, “Journal of the American Statistical Association”, 64, pp. 131-146.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2012 Statistica
This work is licensed under a Creative Commons Attribution 3.0 Unported License.
